De-escalated neoadjuvant chemotherapy in early triple-negative breast cancer (TNBC): Impact of molecular markers and survival analysis of the WSG-ADAPT-TN trial.
暂无分享，去创建一个
N. Harbeck | O. Gluz | S. Kuemmel | A. Prat | R. Kates | U. Nitz | R. Wuerstlein | M. Warm | H. Forstbauer | C. Schumacher | M. Braun | M. Christgen | L. Paré | B. Aktas | J. Hackmann | M. Graeser | E. Pelz | C. Uleer | H. Kreipe | C. Kolberg-Liedtke | C. Zu Eulenburg | K. Jóźwiak | E. Grischke | Daniel Gebauer | Mohammad Parsa Mohammadian